ZD 2138

• UNSPSC Description:

  ZD 2138 is an inhibitor of 5-lipoxygenase. ZD-2138 can alleviate bronchoconstriction induced by aspirin (HY-14654) and can be used in asthma research[1].

• Target Antigen:

  Lipoxygenase

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/zd-2138.html

• Smiles:

  O=C1C=CC2=C(N1C)C=CC(COC3=CC(F)=CC(C4(CCOCC4)OC)=C3)=C2

• Molecular Weight:

  397.44

• References & Citations:

  [1]Drazen J. Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors[J]. American journal of respiratory and critical care medicine, 1998, 157(6): S233-S237.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  140841-32-3